Quarterly report pursuant to Section 13 or 15(d)

Summary of Stock Options Activity (Details)

v3.23.2
Summary of Stock Options Activity (Details)
 6 Months Ended
Jun. 30, 2023
USD ($)
$ / shares
shares
Share-Based Payment Arrangement [Abstract]  
Number of Shares, Beginning Balance | shares 4,476,737
Weighted Average Exercise Price, Beginning Balance $ 2.64
Weighted Average Grant Date Fair Value, Beginning $ 2.64
Weighted Average Remaining Contractual Term (Years), Beginning 7 months 20 days
Aggregate Intrinsic Value, Beginning Balance | $
Number of Shares, Granted | shares 2,745,000
Weighted Average Exercise Price, Granted $ 1.63
Weighted Average Grant Date Fair Value, Granted $ 1.63
Weighted Average Remaining Contractual Term (Years), Granted 8 years 6 months 10 days
Number of Shares, Exercised | shares
Weighted Average Exercise Price, Exercised
Weighted Average Grant Date Fair Value, Exercised
Number of Shares, Forfeited | shares
Weighted Average Exercise Price, Forfeited
Weighted Average Grant Date Fair Value, Forfeited
Number of Shares, Canceled/Expired | shares (4,176,737)
Weighted Average Exercise Price, Canceled/Expired $ 2.59
Weighted Average Grant Date Fair Value, Canceled/Expired $ 2.59
Number of Shares, Ending Balance | shares 3,045,000
Weighted Average Exercise Price, Ending Balance $ 1.80
Weighted Average Grant Date Fair Value, Ending $ 1.80
Weighted Average Remaining Contractual Term (Years), Ending 8 years 2 months 8 days
Aggregate Intrinsic Value, Ending Balance | $
Number of Shares, Exercisable | shares 1,114,999
Weighted Average Exercise Price, Exercisable $ 1.90
Weighted Average Grant Date Fair Value, Exercisable $ 1.90
Weighted Average Remaining Contractual Term (Years), Exercisable 7 years 10 months 9 days
Aggregate Intrinsic Value, Exercisable | $